DxMA :: Diagnostic Testing & Healthcare Industry News Updates

The DxMA wishes to thank the EMMES Group for providing the news updates listed below. For more information on any item, please click on the subject to access a PDF file.

April 2007

Beckman and Inverness Await Response From Biosite; Some Expect Higher Bid

Quest to Acquire AmeriPath in a Transaction Valued at $2 Billion

Cepheid and IL in Strategic Agreement to Develop and Market Tests for Genetic Risk of Thrombosis

Diazyme Receives FDA Approval For Its Direct Enzymatic HbA1c Assay Product

Cepheid Test for Methicillin-Resistant Staphylococcus Aureus (MRSA) Receives FDA Clearance

Cytyc Acquires Adeza Biomedical Corporation

NIH and Institute Pasteur Extend Collaboration Agreement for HIV-1 Diagnostics

Roche to Acquire Bioveris to Expand ECL Immunochemistry Business Into New Market Segments

Siemens Launches New Automated Urine Analyzer For Medium to High Throughput Settings

Axis-Shield Receives 510K Clearance for Anti-CCP Assay on Abbott's AxSYM Analyser

Cepheid Introduces CE Mark Certified Smart HBV Test for SmartCycler System

New Diagnostic Technologies Offer Non-Invasive Means

Epigenomics Claims Clinical Data Show That Colon Polyps Can Be Detected With Simple Blood Test

Urine Test May Predict Diabetic Kidney Disease

With Acquisition of HemoCue, Quest Enters the IVD Market

Diagnostic Industry News Briefs

The Emmes Group is a strategic business development, assessment and planning organization specializing in the support of firms engaged in the technology, internet, biotechnology and pharmaceutical industries. Our partners have over 50 years of combined experience in serving technology, internet and healthcare companies. For more information, click here.

Diagnostic Testing & Healthcare Industry News Updates - Archive

April 2007

Diagnostic Industry News Briefs